Trial Profile
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 May 2012
Price :
$35
*
At a glance
- Drugs Flutamide (Primary) ; Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.